Clinical significance and long-term prognosis of ulcerative colitis patients with appendiceal orifice inflammation

[1]  J. Soh,et al.  Discrete terminal ileal ulcers in patients diagnosed with ulcerative colitis: clinical significance and natural course , 2021, BMC Gastroenterology.

[2]  M. Iwamuro,et al.  Appendiceal Orifice Inflammation in Ulcerative Colitis Mimicking Mucosa-Associated Lymphoid Tissue Lymphoma in the Cecum , 2020, Case reports in gastrointestinal medicine.

[3]  Siddharth Singh,et al.  AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. , 2019, Gastroenterology.

[4]  B. Hou,et al.  Diagnostic evaluation of appendiceal orifice inflammation in ulcerative colitis. , 2016, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[5]  S. Ishihara,et al.  Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[6]  Junchao Wu,et al.  Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis. , 2016, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[7]  E. Loftus,et al.  Appendiceal Skip Inflammation and Ulcerative Colitis , 2014, Digestive Diseases and Sciences.

[8]  L. Greco,et al.  Periappendiceal Inflammation in Pediatric Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[9]  E. Cabré,et al.  Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice. , 2011, Journal of gastrointestinal and liver diseases : JGLD.

[10]  D. Rubin,et al.  The Peri-appendiceal Red Patch in Ulcerative Colitis: Review of the University of Chicago Experience , 2010, Digestive Diseases and Sciences.

[11]  F. Ajayi,et al.  Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial , 2005, The American Journal of Gastroenterology.

[12]  G. Lee,et al.  Clinical Course of Distal Ulcerative Colitis in Relation to Appendiceal Orifice Inflammation Status , 2005, Inflammatory bowel diseases.

[13]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[14]  M. Shimizu,et al.  Significance of appendiceal involvement in patients with ulcerative colitis. , 2002, Gastrointestinal endoscopy.

[15]  W. Hong,et al.  Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: an analysis in relation to medical therapy and disease extent. , 1999, Gastrointestinal endoscopy.

[16]  P. Rutgeerts,et al.  Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. , 1997, The American journal of gastroenterology.

[17]  C. Bernstein,et al.  Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. , 1995, Gastrointestinal endoscopy.

[18]  J. Goldblum,et al.  Appendiceal involvement in ulcerative colitis. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[19]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.